Related Experiment Video
Updated: Feb 16, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
Published on: October 10, 2012
Response biomarkers in neonatal intervention studies
Lauren E Kelly1, Kimberly Caswell2, Mary A Short3
1Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada.
Most neonatal intensive care unit (NICU) drugs lack testing. This review found significant variability in how response biomarkers are reported in neonatal clinical trials, hindering drug development.
Area of Science:
- Neonatal pharmacology
- Biomarker research
- Clinical trial methodology
Background:
- Up to 90% of drugs used in neonatal intensive care units (NICUs) lack clinical testing for safety and efficacy.
- Developing and validating neonatal response biomarkers is crucial for advancing drug development.
- This review assesses the quality of response biomarker reporting in neonatal clinical trials.
Purpose of the Study:
- To evaluate the quality of response biomarker reporting in neonatal clinical trials.
- To identify common practices and areas for improvement in biomarker reporting.
Main Methods:
- A validated literature search strategy was employed.
- Prospective neonatal intervention studies reporting response biomarkers published in 2014 were included.
- Data extraction was performed independently and in duplicate.
Main Results:
- 167 prospective neonatal trials were analyzed, with 35% reporting response biomarkers.
- 275 biomarkers were identified for measuring response (pharmacodynamics and safety).
- Heart rate and oxygen saturation were most common; measurement and instrumentation data were often missing.
Conclusions:
- Significant variability exists in the selection, measurement, and reporting of neonatal response biomarkers.
- Improved reporting initiatives are necessary to reduce research waste.
- Enhancing biomarker reporting will improve the reproducibility of their use in neonatal studies.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Nursing Interventions I: Taxonomy of Nursing Interventions
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Heart Failure VII: Nursing Interventions

